KMT2C and KMT2D regulate skeletal development through stage-specific epigenetic control of chondrogenesis
5 affiliations
- 1Department of Genetics, University of North Carolina, Chapel Hill, NC USA
- 2Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, NC USA
- 3Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD USA
- 4Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC USA
- 5Department of Physiology and Pharmacology, College of Veterinary Medicine, University of Georgia, Athens, GA USA
Abstract
Many craniofacial disorders linked to mutations in enhancer-associated chromatin modifiers, including Kabuki syndrome (KS), present with skeletal abnormalities. KS is a craniofacial developmental disorder characterized by mutations in KMT2D, a histone H3 lysine 4 (H3K4) methyltransferase. The cellular origins and molecular pathways leading to KMT2D-dependent skeletal deficits in KS are not well characterized. We previously demonstrated that KMT2D deletion in mouse cranial neural crest cells (cNCCs), multipotent stem cells contributing to craniofacial structures, impairs chondrocyte hypertrophic differentiation. Although we observed defects in cNCC endochondral ossification, KMT2D’s broader skeletal role remains unclear and its functional redundancy in skeletal development with its paralog, KMT2C, is understudied. We now find that KMT2D mutation within chondrocyte lineages results in postnatal growth defects. Chondrocytes deficient in both methyltransferases yield severe deficits in bone formation, revealing redundant roles for KMT2C/D in endochondral ossification. These methyltransferases regulate chondrocyte state transitions as hypertrophic differentiation is impaired with loss of KMT2C/D. When both methyltransferases are deleted in stem cell lineages, cNCCs fail to induce factors downstream of SOX9 activation. At the molecular level, H3K4me1 is lost at de novo chondrocyte enhancers essential for skeletal development, accompanied by reduced H3K27ac deposition, indicating KMT2C/D-dependent enhancer priming. We indicate roles for KMT2C/D in facilitating activation of genes downstream of SOX9 and RUNX2 transcription factors. Our findings define a regulatory cascade mediated by chromatin-level modifications to ensure commitment of chondrocyte lineages, expanding the known roles of histone modifiers and offering insights into the epigenetic underpinnings of skeletal dysplasia and related congenital disorders.
Related
- p75 NTR orchestrates chondrogenesis and mechanoadaptation to preserve temporomandibular joint development and homeostasis
- Ultra-sensitive Mapping of Cell-free DNA-derived Methylomes Reveals Brain-specific Epigenetic Alterations Implicated in Alzheimer Disease
- RNF152 promoter methylation and gene expression in oral premalignant lesions and oral squamous cell carcinoma: implications for epigenetic biomarker development
- Adma and Ackr3a regulate cardiac lymphatic vessel formation and function during heart development and regeneration
- Microglia regulate nucleus accumbens synaptic development and circuit function underlying threat avoidance behaviors in mice
BibTeX
@article{quickstad2026kmt2c,
title = {{KMT2C and KMT2D regulate skeletal development through stage-specific epigenetic control of chondrogenesis}},
author = {Gabrielle Quickstad and Dimitrios V. Bikas and Marielle L. Bond and Sara Vardabasso and Andrew N. Wyper and Young-Kwon Park and Kai Ge and Richard F. Loeser and Terry Magnuson and Karl B. Shpargel},
journal = {Bone Research},
year = {2026},
month = oct,
doi = {10.1038/s41413-026-00584-8},
url = {https://doi.org/10.1038/s41413-026-00584-8},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - KMT2C and KMT2D regulate skeletal development through stage-specific epigenetic control of chondrogenesis
AU - Gabrielle Quickstad
AU - Dimitrios V. Bikas
AU - Marielle L. Bond
AU - Sara Vardabasso
AU - Andrew N. Wyper
AU - Young-Kwon Park
AU - Kai Ge
AU - Richard F. Loeser
AU - Terry Magnuson
AU - Karl B. Shpargel
PY - 2026
DA - 2026/10/27
JO - Bone Research
DO - 10.1038/s41413-026-00584-8
UR - https://doi.org/10.1038/s41413-026-00584-8
AB - Many craniofacial disorders linked to mutations in enhancer-associated chromatin modifiers, including Kabuki syndrome (KS), present with skeletal abnormalities. KS is a craniofacial developmental disorder characterized by mutations in KMT2D, a histone H3 lysine 4 (H3K4) methyltransferase. The cellular origins and molecular pathways leading to KMT2D-dependent skeletal deficits in KS are not well characterized. We previously demonstrated that KMT2D deletion in mouse cranial neural crest cells (cNCCs), multipotent stem cells contributing to craniofacial structures, impairs chondrocyte hypertrophic differentiation. Although we observed defects in cNCC endochondral ossification, KMT2D’s broader skeletal role remains unclear and its functional redundancy in skeletal development with its paralog, KMT2C, is understudied. We now find that KMT2D mutation within chondrocyte lineages results in postnatal growth defects. Chondrocytes deficient in both methyltransferases yield severe deficits in bone formation, revealing redundant roles for KMT2C/D in endochondral ossification. These methyltransferases regulate chondrocyte state transitions as hypertrophic differentiation is impaired with loss of KMT2C/D. When both methyltransferases are deleted in stem cell lineages, cNCCs fail to induce factors downstream of SOX9 activation. At the molecular level, H3K4me1 is lost at de novo chondrocyte enhancers essential for skeletal development, accompanied by reduced H3K27ac deposition, indicating KMT2C/D-dependent enhancer priming. We indicate roles for KMT2C/D in facilitating activation of genes downstream of SOX9 and RUNX2 transcription factors. Our findings define a regulatory cascade mediated by chromatin-level modifications to ensure commitment of chondrocyte lineages, expanding the known roles of histone modifiers and offering insights into the epigenetic underpinnings of skeletal dysplasia and related congenital disorders.
SN - 2095-4700
SN - 2095-6231
ER -